Merck KGaA drops after outlook 2026, stable dividend 'disappoint'

Merck KGaA

05/03/2026 07:14

** Shares in German healthcare company Merck KGaA MRCG.DE are down 6.5% in early Frankfurt trade after 2026 outlook and dividend lag expectations

** The company anticipates 2026 sales between EUR 20–21.1 bln ($23.2-$24.5) vs consensus of EUR 21.05 bln and adjusted EBITDA between EUR 5.5-6 bln vs EUR 5.87 bln seen in consensus by Vara Research

** A local trader says the outlook was "not good" as consensus was already at upper end of range

** The unchanged dividend proposal of EUR 2.2 was also a "slight disappointment", the trader adds

($1 = 0.8619 euros)

(Reporting by Amir Orusov)

((Amir.orusov@thomsonreuters.com))